Market Cap 95.06M
Revenue (ttm) 0.00
Net Income (ttm) -28.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,203,700
Avg Vol 1,125,964
Day's Range N/A - N/A
Shares Out 127.51M
Stochastic %K 9%
Beta 1.15
Analysts Strong Sell
Price Target $4.42

Company Profile

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored...

Industry: Biotechnology
Sector: Healthcare
Phone: 403 670 7377
Fax: 403 283 0858
Address:
4350 Executive Drive, Suite 325, San Diego, United States
taotrader
taotrader Sep. 11 at 9:03 PM
$ONCY why is that every biotech stock I only lately reports positive results in a trial and then proceeds to go down? Very frustrating
0 · Reply
Myman2
Myman2 Sep. 11 at 4:04 PM
$ONCY I don't believe there is any manipulation. The fact of the matter is all small caps are acting lousy because rates are going up and more importantly the market is not getting the news it wants!
1 · Reply
Merlintrader
Merlintrader Sep. 11 at 4:02 PM
$ONCY — New preclinical colorectal-cancer data show pelareorep retained activity alongside pan-RAS inhibition, with no evidence of antagonism. Updated https://www.merlintrader.com/oncolytics-biotech-stock-hub/
1 · Reply
Myman2
Myman2 Sep. 11 at 4:00 PM
$ONCY I already have more then I should, but I just bought some more at $.7450
0 · Reply
GoPatzGo123
GoPatzGo123 Sep. 11 at 3:46 PM
$ONCY honestly thought i was getting a deal buying in the low .80's ....manipulated as someone mentioned? What would be the reason for that?
0 · Reply
OncyBull
OncyBull Sep. 11 at 2:49 PM
$ONCY Can someone explain how it’s being manipulated? It’s a penny stock for a reason: financial distress and hasn’t proven anything tangible in eyes of FDA/market.
2 · Reply
NoName_1
NoName_1 Sep. 11 at 2:32 PM
$ONCY im so glad we had news yesterday... no telling what the stock price would have done without it... 🤔
0 · Reply
aaron03
aaron03 Sep. 11 at 1:43 PM
$ONCY I truly am bewildered by the share price for $ONCY. It sure does have the appearance of pure manipulation. I'm certainly not selling my shares, but it's getting to the point now where I can admit that it's been one of my worst investments. Truly disappointed
2 · Reply
Golden_Cross
Golden_Cross Sep. 11 at 5:09 AM
$ONCY ~ Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer 🔗 https://stocktitan.net/news/ONCY/oncolytics-biotech-announces-positive-preclinical-results-combining-1e7es4pirxrv.html #NEWS
0 · Reply
NoName_1
NoName_1 Sep. 11 at 12:26 AM
0 · Reply
Latest News on ONCY
Oncolytics reports pelareorep preclinical results

2026-09-10T12:20:10.000Z - 2 days ago

Oncolytics reports pelareorep preclinical results


Oncolytics Biotech Quarterly report: Q2 2026

Aug 12, 2026, 7:00 AM EDT - 4 weeks ago

Oncolytics Biotech Quarterly report: Q2 2026


Oncolytics provides clinical, regulatory update on REO 033

2026-07-13T13:10:54.000Z - 2 months ago

Oncolytics provides clinical, regulatory update on REO 033


Oncolytics secures new patent for pelareorep manufacturing

2026-06-16T13:38:20.000Z - 2 months ago

Oncolytics secures new patent for pelareorep manufacturing


Oncolytics promotes John McAdory to COO

2026-06-02T14:21:34.000Z - 3 months ago

Oncolytics promotes John McAdory to COO

CGON


Oncolytics Biotech Slides: Investor presentation

Jun 1, 2026, 7:00 AM EDT - 3 months ago

Oncolytics Biotech Slides: Investor presentation


Oncolytics Biotech to present data at ASCO 2026 on pelareorep

2026-05-22T13:45:50.000Z - 3 months ago

Oncolytics Biotech to present data at ASCO 2026 on pelareorep


Oncolytics Biotech Quarterly report: Q1 2026

May 14, 2026, 4:00 PM EDT - 4 months ago

Oncolytics Biotech Quarterly report: Q1 2026


Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study

Apr 27, 2026, 8:10 AM EDT - 4 months ago

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study


Oncolytics Biotech Slides: Investor presentation

Apr 27, 2026, 7:00 AM EDT - 4 months ago

Oncolytics Biotech Slides: Investor presentation


Oncolytics price target lowered to $5 from $7 at Lake Street

2026-04-07T14:24:37.000Z - 5 months ago

Oncolytics price target lowered to $5 from $7 at Lake Street


Oncolytics completes domicile change to the U.S.

2026-04-01T13:39:37.000Z - 5 months ago

Oncolytics completes domicile change to the U.S.


Oncolytics Biotech Registration statement: Registration filing

Apr 1, 2026, 8:00 AM EDT - 5 months ago

Oncolytics Biotech Registration statement: Registration filing


Oncolytics files $250M mixed securities shelf

2026-04-01T10:11:38.000Z - 5 months ago

Oncolytics files $250M mixed securities shelf


Oncolytics Biotech Annual report: Q4 2025

Mar 30, 2026, 7:00 AM EDT - 5 months ago

Oncolytics Biotech Annual report: Q4 2025


Oncolytics to present new data on Pelareorep at AACR 2026

2026-03-19T13:16:47.000Z - 5 months ago

Oncolytics to present new data on Pelareorep at AACR 2026


Oncolytics Biotech Slides: Corporate presentation

Mar 3, 2026, 6:00 AM EST - 6 months ago

Oncolytics Biotech Slides: Corporate presentation


Oncolytics initiates randomized colorectal cancer study

2026-03-02T14:12:44.000Z - 6 months ago

Oncolytics initiates randomized colorectal cancer study


Oncolytics concludes enrollment in GOBLET study

2026-02-24T14:05:55.000Z - 6 months ago

Oncolytics concludes enrollment in GOBLET study


Oncolytics receives FDA Fast Track Designation for pelareorep

2026-02-04T13:55:27.000Z - 7 months ago

Oncolytics receives FDA Fast Track Designation for pelareorep


Oncolytics Biotech Transcript: AGM 2026

Jan 15, 2026, 10:00 AM EST - 8 months ago

Oncolytics Biotech Transcript: AGM 2026


Oncolytics Biotech Slides: Investor presentation

Jan 14, 2026, 7:00 AM EST - 8 months ago

Oncolytics Biotech Slides: Investor presentation


Oncolytics announces updates data from GOBLET cohort 4

2026-01-12T14:10:53.000Z - 8 months ago

Oncolytics announces updates data from GOBLET cohort 4


Oncolytics Biotech Earnings release: Q3 2025

Nov 11, 2025, 6:00 PM EST - 10 months ago

Oncolytics Biotech Earnings release: Q3 2025


Oncolytics Biotech Transcript: AGM 2025

Aug 8, 2025, 10:00 AM EDT - 1 year ago

Oncolytics Biotech Transcript: AGM 2025


Oncolytics Biotech Earnings release: Q2 2025

Aug 8, 2025, 10:00 AM EDT - 1 year ago

Oncolytics Biotech Earnings release: Q2 2025


Oncolytics Biotech Transcript: Status Update

Jul 22, 2025, 1:00 PM EDT - 1 year ago

Oncolytics Biotech Transcript: Status Update


Oncolytics Biotech Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Oncolytics Biotech Earnings Call Transcript: Q1 2025


Oncolytics Biotech Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Oncolytics Biotech Earnings release: Q1 2025


taotrader
taotrader Sep. 11 at 9:03 PM
$ONCY why is that every biotech stock I only lately reports positive results in a trial and then proceeds to go down? Very frustrating
0 · Reply
Myman2
Myman2 Sep. 11 at 4:04 PM
$ONCY I don't believe there is any manipulation. The fact of the matter is all small caps are acting lousy because rates are going up and more importantly the market is not getting the news it wants!
1 · Reply
Merlintrader
Merlintrader Sep. 11 at 4:02 PM
$ONCY — New preclinical colorectal-cancer data show pelareorep retained activity alongside pan-RAS inhibition, with no evidence of antagonism. Updated https://www.merlintrader.com/oncolytics-biotech-stock-hub/
1 · Reply
Myman2
Myman2 Sep. 11 at 4:00 PM
$ONCY I already have more then I should, but I just bought some more at $.7450
0 · Reply
GoPatzGo123
GoPatzGo123 Sep. 11 at 3:46 PM
$ONCY honestly thought i was getting a deal buying in the low .80's ....manipulated as someone mentioned? What would be the reason for that?
0 · Reply
OncyBull
OncyBull Sep. 11 at 2:49 PM
$ONCY Can someone explain how it’s being manipulated? It’s a penny stock for a reason: financial distress and hasn’t proven anything tangible in eyes of FDA/market.
2 · Reply
NoName_1
NoName_1 Sep. 11 at 2:32 PM
$ONCY im so glad we had news yesterday... no telling what the stock price would have done without it... 🤔
0 · Reply
aaron03
aaron03 Sep. 11 at 1:43 PM
$ONCY I truly am bewildered by the share price for $ONCY. It sure does have the appearance of pure manipulation. I'm certainly not selling my shares, but it's getting to the point now where I can admit that it's been one of my worst investments. Truly disappointed
2 · Reply
Golden_Cross
Golden_Cross Sep. 11 at 5:09 AM
$ONCY ~ Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer 🔗 https://stocktitan.net/news/ONCY/oncolytics-biotech-announces-positive-preclinical-results-combining-1e7es4pirxrv.html #NEWS
0 · Reply
NoName_1
NoName_1 Sep. 11 at 12:26 AM
0 · Reply
PrintingGains
PrintingGains Sep. 10 at 10:11 PM
$ONCY loading zone right here thank me later.
1 · Reply
JohnnyC63
JohnnyC63 Sep. 10 at 8:18 PM
$ONCY Folks, we all know this is massively manipulated stock, and as such anything short of a buyout or partnership announcement will have little to know effect on stock price. But that means ZERO for the effectiveness of Pelareorep and the direction that Jared Kelly is taking the company. He is doing EVERYTHING needed to move us ahead towards that endgame goal. Just think where we would be right now if Matt Coffey were still at the helm; lots of amazing trial results and no closer to a deal than in 2015. That is actually terrifying when I think back to the "excitement" I had over those years before JK, not realizing we were going nowhere biz dev-wise. Sit back, enjoy the successful NRs as they come out, and know the endgame actually is getting closer - whatever timeline that is (within 2 years max IMHO)
1 · Reply
DipBuyInvester
DipBuyInvester Sep. 10 at 8:04 PM
$ONCY Loading opportunity in dip. Sentiment has not changed. It’s all about cancer!!
0 · Reply
AI1234
AI1234 Sep. 10 at 7:54 PM
$ONCY IMO, the press release and action today reflects another coordinated money raise. Method of Use, an executed Business Agreement and actual positive efficacy are the primary catalysts to increase SP at this point. Most other information - chats, paid advertising etc. is smoke and mirrors.
1 · Reply
SilverWS
SilverWS Sep. 10 at 7:44 PM
$ONCY Well sold all my shares today .. That's enough
1 · Reply
FoxM07
FoxM07 Sep. 10 at 7:16 PM
0 · Reply
FoxM07
FoxM07 Sep. 10 at 7:16 PM
0 · Reply
FoxM07
FoxM07 Sep. 10 at 7:16 PM
0 · Reply
NoName_1
NoName_1 Sep. 10 at 7:06 PM
0 · Reply
Greenkeeper11
Greenkeeper11 Sep. 10 at 7:05 PM
$ONCY all the squawking on this board is not gonna change the end game. I think I’m just gonna go grab a couple of cold ones and head to the lake and patiently wait for payday. probably next year sometime or early 2028 like Casey said.
0 · Reply
GoPatzGo123
GoPatzGo123 Sep. 10 at 6:59 PM
$ONCY help me understand why the fuck this is trading in the 70's on news this morning?
2 · Reply
Notable_Ex
Notable_Ex Sep. 10 at 6:55 PM
$ONCY Read this - https://stockhouse.com/companies/bullboard?symbol=oncy&threadid=37110570
0 · Reply